It has been reported that FBLN5 was significantly down-regulated in ovarian cancer [24], breast cancer [42], and lung cancer [28], and FBLN5 over-expression inhibited cells proliferation and metastasis. The gene discussed is FBLN5; the disease is ovarian carcinoma.